Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
As fears of recession loom, the consumer price index up 6.5 percent and inflation at historic highs, funds that Americans saved during the COVID-19 pandemic are nearing depletion.
Mario Veneroso, partner & wealth manager with Kingsview Asset Management, joined Cheddar News to discuss Monday's trading session following last week's Fed decision to hike rates as well as Friday's jobs data.
Kelley Long, CPA, personal finance specialist and certified financial planner, joined Cheddar News to offer tips on how people can protect themselves from tax-related scams during the filing season.